ARTICLE | Company News

Management tracks

July 22, 2016 7:00 AM UTC

Boston Pharmaceuticals (Cambridge, Mass.) named Ian Sanderson CFO. He was CFO at Catabasis Pharmaceuticals Inc. (NASDAQ:CATB). Boston plans to in-license products that are in preclinical or early clinical testing, develop them through Phase II proof-of-concept, and then sell each asset back to its originator or out-license it to a third party. ...